Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Evangelina Esposito is active.

Publication


Featured researches published by Evangelina Esposito.


BMC Ophthalmology | 2017

Blue-light filtering alters angiogenic signaling in human retinal pigmented epithelial cells culture model.

Natalia Vila; Aya Siblini; Evangelina Esposito; Vasco Bravo-Filho; Pablo Zoroquiain; Sultan Aldrees; Patrick Logan; Lluis Arias; Miguel N. Burnier

BackgroundLight exposure and more specifically the spectrum of blue light contribute to the oxidative stress in Age-related macular degeneration (AMD). The purpose of the study was to establish whether blue light filtering could modify proangiogenic signaling produced by retinal pigmented epithelial (RPE) cells under different conditions simulating risk factors for AMD.MethodsThree experiments were carried out in order to expose ARPE-19 cells to white light for 48xa0h with and without blue light-blocking filters (BLF) in different conditions. In each experiment one group was exposed to light with no BLF protection, a second group was exposed to light with BLF protection, and a control group was not exposed to light. The ARPE-19 cells used in each experiment prior to light exposure were cultured for 24xa0h as follows: Experiment 1) Normoxia, Experiment 2) Hypoxia, and Experiment 3) Lutein supplemented media in normoxia. The media of all groups was harvested after light exposure for sandwich ELISA-based assays to quantify 10 pro-angiogenic cytokines.ResultsA significant decrease in angiogenin secretion levels and a significant increase in bFGF were observed following light exposure, compared to dark conditions, in both normoxia and hypoxia conditions. With the addition of a blue light-blocking filter in normoxia, a significant increase in angiogenin levels was observed. Although statistical significance was not achieved, blue light filters reduce light-induced secretion of bFGF and VEGF to near normal levels. This trend is also observed when ARPE-19 cells are grown under hypoxic conditions and when pre-treated with lutein prior to exposure to experimental conditions.ConclusionsFollowing light exposure, there is a decrease in angiogenin secretion by ARPE-19 cells, which was abrogated with a blue light - blocking filter. Our findings support the position that blue light filtering affects the secretion of angiogenic factors by retinal pigmented epithelial cells under normoxic, hypoxic, and lutein-pretreated conditions in a similar manner.


International Journal of Surgical Pathology | 2016

Epithelial Inclusion Cyst in Conjunctival Melanoma

Evangelina Esposito; Pablo Zoroquiain; Christina Mastromonaco; Melina Morales; Rubens Belfort Neto; Miguel N. Burnier

Conjunctival melanoma is the second most common conjunctival malignancy. Its differential diagnosis with other conjunctival melanocytic neoplasms is inherently difficult. The presence of epithelial cysts is a useful feature in conjunctival tumors and favors a benign lesion. Herein 2 cases of conjunctival melanoma with cysts are presented. To the best of our knowledge, this is the first series of conjunctival melanoma with epithelial inclusion cysts. This series emphasizes the importance of considering several malignant features when reviewing conjunctival melanocytic lesions, as malignancy can exist even in the presence of epithelial inclusion cysts.


Current Eye Research | 2018

Removing Subjective Post-Mortem Grading from Posterior Capsular Opacification: A New Automated Detector Opacification Software, ADOS

Christina Mastromonaco; Matthew Balazsi; Pablo Zoroquiain; Evangelina Esposito; Jacqueline Coblentz; Patrick Logan; Miguel N. Burnier

ABSTRACT Purpose/aim: Posterior capsular opacification (PCO) is the leading complication following cataract surgery. However, PCO grading methods vary between studies and rely on subjective scoring methods; hence, they are prone to error. Therefore, software that reduces subjectivity and enhances reproducibility is needed. The aim of the study was to evaluate the reproducibility and objectivity of a novel automated custom-designed PCO detection software. Materials and Methods: In total, 165 fixed eyes with intraocular lenses were sectioned to obtain a Miyake Apple view (MAV) image. The capsular bag (CB) with the in situ IOL was removed and imaged using the Olympus DSX110 stereoscope. Central, peripheral, and Soemmering’s ring area (SRA) and intensity (SRI) were graded by two ophthalmologists using a scale of 0–4. Software was developed to detect PCO, and these values were correlated with subjective scoring. Results: Intra-observer agreement for MAV and CB images ranged from poor to moderate, with very good agreement for SRI (k = 0.88, 0.86, respectively). Agreement between graders was fair to good (k = 0.31–0.77). Miyake Apple view and capsular bag images showed good correlation; central PCO showed the least correlation for both evaluators (k = 0.29, 0.72). Subjective average grading versus software correlation demonstrated very good correlation for intensity and good for area (r = 0.85, 0.61). Reproducibility of the methodology resulted in good to very good correlation. Conclusions: Software correlates with previous scoring methods and is a reliable and reproducible system. Moreover, the capsular bag view, as opposed to the Miyake Apple view, allows visualization of the capsular bag directly and avoids overlapping structures (vitreous, cornea) that may interfere with proper PCO quantification.


Ocular Oncology and Pathology | 2017

HER2 Overexpression in Retinoblastoma: A Potential Therapeutic Target

David Cordeiro Sousa; Pablo Zoroquiain; Maria Eugenia Orellana; Ana Beatriz Toledo Dias; Evangelina Esposito; Miguel N. Burnier

Background: Retinoblastoma (RB) is the most common primary intraocular malignancy. Current therapies are associated with high morbidity in the short- and long-term. Human epidermal growth factor receptor 2 (HER2) is a transmembrane protein detected in 15-30% of breast cancers, but it has also been described in other malignancies. Recently, it has been claimed that a truncated version of this protein is expressed in RB, responsive to directed therapies in vitro. We scored HER2 overexpression in RB tissue samples and discussed its potential clinical utility. Methods: HER2 overexpression was investigated using immunohistochemistry; the overexpression was evaluated with a score ranging from 0 to 3+ according to the membranous staining pattern in archival formalin-fixed, paraffin-embedded RBs. Results: A total of 60 RB cases and a RB cell line (Y79) were considered. The mean age at enucleation was 31.6 ± 31.5 months. The mean time from diagnosis to enucleation was 11.8 ± 11.2 months (range 1-44). Five (8%) cases were multifocal. HER2 overexpression was negative in all RB cases (49 cases scored 0 and 11 scored 1+) and in the Y79 cell line. Conclusions: Overall, we were not able to demonstrate the overexpression of HER2. Further studies should clarify and better elucidate the potential role of HER2-targeted therapies in RB.


Choroidal Disorders | 2017

Chapter 3 – Choroidal Histopathology

Evangelina Esposito; Pablo Zoroquiain; Christina Mastromonaco; Jade Lasiste; Sultan Aldrees; Carlos A. Moreira Neto; Jacqueline Coblentz; Rayan Alshareef; Miguel N. Burnier

The choroid provides the main blood supply to the eye and plays a key role in eye physiology. Different entities can compromise its structure and function, having a striking impact on vision. Knowing the histology of the normal eye is fundamental for the correct understanding of the pathologic processes. This chapter is therefore organized into pathological subcategories defined as congenital, inflammatory, and neoplastic processes. The correlation between these different entities and the histopathology would allow us to have the right interpretation of the interaction between the eye, the patient, and the disease, opening the field to different treatments and improving quality among health providers.


Arquivos Brasileiros De Oftalmologia | 2017

Evaluation of nicotinamide as an anti-inflammatory and anti-angiogenic agent in uveal melanoma cell lines

Evangelina Esposito; Sultan Aldrees; Christina Mastromonaco; Pablo Zoroquiain; Natalia Vila; Patrick Logan; Shriya Hari; Miguel N. Burnier

Purpose:nTo investigate the effect of nicotinamide on the secretion of pro-an giogenic and pro-inflammatory cytokines in uveal melanoma cell lines.nnnMethods:nTwo human uveal melanoma cell lines (92.1 and OCM-1) were treated with nicotinamide (10 mmol/L) or control media for 48 hours in culture. The su perna tant from each culture was used in sandwich enzyme-linked immuno sorbent assay-based angiogenesis and inflammation arrays to evaluate the effects of exogenously administered nicotinamide on the secretion of a total of 20 pro-an gio genic and pro-inflammatory proteins.nnnResults:nSeven pro-angiogenic cytokines were detected under control conditions for both uveal melanoma cell lines. Treatment with nicotinamide resulted in a significant decrease in secretion of the following pro-angiogenic cytokines: angiogenin, angiopoietin-2, epidermal growth factor, and vascular epithelial growth factor-A in the 92.1 cells; basic fibroblast growth factor in the OCM-1 cells; and placenta growth factor in both cell lines. Among the pro-inflammatory proteins, monocyte chemotactic protein-1 and interleukin-8 were expressed in both untreated cell lines and both were significantly reduced when treated with nicotinamide.nnnConclusions:nResults from this in vitro model suggest that nicotinamide may have anti-inflammatory and anti-angiogenic properties, which may open the possibility of using it as a chemopreventive agent for uveal melanoma; however, further studies including animal models are warranted.


Human Pathology: Case Reports | 2018

Cytokeratin 7 negative and cytokeratin 20 positive orbital metastatic breast carcinoma

Sabrina Bergeron; Pablo Zoroquiain; Evangelina Esposito; Bryan Arthurs; Miguel N. Burnier


Investigative Ophthalmology & Visual Science | 2017

Intraocular lens biocompatibility: a novel, objective approach

Christina Mastromonaco; Matthew Balazsi; Evangelina Esposito; Jacqueline Coblentz; Aya Siblini; Jade Lasiste; Miguel N. Burnier


Investigative Ophthalmology & Visual Science | 2017

HER2 expression in retinoblastoma: a potential therapeutic target?

David Cordeiro Sousa; Pablo Zoroquiain; Evangelina Esposito; Maria Eugenia Orellana; Bruna Duarte Moron de Andrade; Miguel N. Burnier


Investigative Ophthalmology & Visual Science | 2017

Expression of anaplastic lymphoma kinase in uveal melanoma

Jacqueline Coblentz; Patrick Logan; Ana Beatriz Toledo Dias; Evangelina Esposito; Jose Joao Mansure; Miguel N. Burnier

Collaboration


Dive into the Evangelina Esposito's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge